Kidney health awareness month: a look back at our year

March is dedicated to kidney health awareness, with National Kidney Month, World Kidney Day and Diabetes Alert Day all drawing attention to the growing global burden of kidney disease.

Our mission is to accelerate the development of novel therapies for kidney disease by combining scientific excellence with robust, highly translational preclinical models. Our models cover the spectrum from acute kidney injury to chronic kidney disease and diabetic nephropathy, supported by in vivo imaging, biomarker discovery, non-invasive GFR and blood pressure measurement, histopathology, and bulk and single-cell transcriptomics.

Highlights from the past year include collaborating with several new clients to evaluate the therapeutic efficacy of their drug candidates, developing new preclinical models, and connecting with colleagues at ASN Kidney Week — where we were proud to see our scientific advisor Rafael Kramann receive the Donald W. Seldin Young Investigator Award for his work in renal fibrosis.

If your pipeline includes a renal indication and you are looking for a scientific partner with deep expertise in preclinical kidney disease models, we would welcome the conversation.